Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, May 31, 2016

Patient associations: a key catalyst for hepatitis advocacy and impact

Patient associations: a key catalyst for hepatitis advocacy and impact

The experts in the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a window on the broad range of hepatitis activities and perspectives in Europe today. Hep-CORE PI Jeffrey Lazarus has been interviewing some of them about how they came to work with viral hepatitis, how the field has been changing, and what new research is called for.

Jeffrey V. Lazarus

The seventh interview in the series is with Charles Gore, Chief Executive and co-founder of The Hepatitis C Trust in the United Kingdom, and founder of the World Hepatitis Alliance (WHA)

      




No comments:

Post a Comment